Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Equity (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Return on Equity readings, the most recent being 0.03% for Q4 2025.

  • On a quarterly basis, Return on Equity rose 5.0% to 0.03% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.03%, a 5.0% increase, with the full-year FY2025 number at 0.07%, up 22.0% from a year prior.
  • Return on Equity hit 0.03% in Q4 2025 for Lucid Diagnostics, roughly flat from 0.03% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.01% in Q3 2021 to a low of 88.32% in Q1 2025.
  • Median Return on Equity over the past 5 years was 0.03% (2025), compared with a mean of 5.2%.
  • Biggest five-year swings in Return on Equity: soared 422bps in 2024 and later crashed -8822bps in 2025.
  • Lucid Diagnostics' Return on Equity stood at 0.02% in 2021, then fell by -21bps to 0.02% in 2022, then tumbled by -19257bps to 4.3% in 2023, then surged by 98bps to 0.08% in 2024, then soared by 59bps to 0.03% in 2025.
  • The last three reported values for Return on Equity were 0.03% (Q4 2025), 0.03% (Q3 2025), and 0.44% (Q2 2025) per Business Quant data.